Clinical Trials
Tuesday, November 20th, 2012
American Heart Association: November 13, 2012 Background—Blacks have disproportionately high rates of cardiovascular disease. Psychosocial stress may contribute to this disparity. Previous trials on stress reduction with the Transcendental Meditation (TM) program have reported improvements in cardiovascular disease risk factors, surrogate end points, and mortality in blacks and other populations. Methods and Results—This was a randomized, […]
Clinical Trials
Tuesday, November 20th, 2012
SSRIs include Prozac, Paxil, but experts say findings aren’t reason for patients to drop medications healthday: By E.J. Mundell HealthDay Reporter, 11/8/12 THURSDAY, Nov. 8 (HealthDay News) — Millions of older Americans take the blood thinner warfarin, and many may also take one of a widely used class of antidepressants called SSRIs. Now, a new study finds that […]
Clinical Trials
Tuesday, November 20th, 2012
BMJ: October 15, 2012 To do an indirect comparison analysis of apixaban against dabigatran etexilate (2 doses) and rivaroxaban (1 dose), as well as of rivaroxaban against dabigatranetexilate (2 doses), for their relative efficacy and safety against each other, with particular focus on the secondary prevention population for stroke prevention in atrial fibrillation. A secondary […]
Clinical Trials
Tuesday, November 20th, 2012
Wiley: 11/4/12 We aimed to evaluate the feasibility of an oral direct thrombin inhibitor, dabigatran, as a periprocedural anticoagulant for use with ablation of atrial fibrillation (AF). Methods Consecutive patients scheduled to undergo an AF ablation were randomly assigned to receive dabigatran (n = 45) or warfarin (n = 45) to compare their clinical feasibility. Both […]
Therapies
Tuesday, November 20th, 2012
The University of Queensland: November 09, 2012 A non-robotic device that helps stroke survivors regain upper limb movement is expected to be commercially available in Australia within the next 12 months. Sensory-Motor Active Rehabilitation Training Arm (SMART Arm) is a device developed by researchers from The University of Queensland and James Cook University. The device enables […]
Therapies
Tuesday, November 20th, 2012
Teresa Wong, Executive Director, REHAB Innovation Center: Teresa Wong leads a “think tank” created to facilitate innovative synergies between clinicians, scientists, and community partners locally, nationally and internationally. Fusing her 20 years of clinical expertise with her understanding of rapidly developing technologies, she challenges the premise of what physical rehabilitation ought to be. Teresa has […]
News
Tuesday, November 20th, 2012
American Heart Association: November 13, 2012 Background and Purpose—Compare access and outcomes in a tertiary care community hospital (Saint Luke’s Neuroscience Institute) and its stroke network to hospitals in 3 national databases. Methods—Retrospective analysis of ischemic stroke patients (2005, 2007, 2010) in Saint Luke’s (n=1576), Get With The Guidelines-Stroke (n=423 809), Premier (n=91 598), and Merci […]
News
Tuesday, November 20th, 2012
American Heart Association: November 13, 2012 Background and Purpose—Although many stroke patients are young or middle-aged, risk factor profiles in these age groups are poorly understood. Methods—The Stroke in Young Fabry Patients (sifap1) study prospectively recruited a large multinational European cohort of patients with cerebrovascular events aged 18 to 55 years to establish their prevalence of […]
News
Tuesday, November 20th, 2012
Medicalxpress: November 11, 2012 For years, researchers have known that antiphospholipid antibodies (aPLs) can cause pregnancy loss and clotting, but they haven’t known the true scope of the problem. Now a new study provides the first estimates of the prevalence of these antibodies in patients suffering from pregnancy loss, stroke, myocardial infarction, and deep vein […]
News
Tuesday, November 20th, 2012
Society of NeuroInterventional Surgery: 11/10/12 Introduction Outcome after stroke intervention remains disappointing, with only 30–50% of patients having a good outcome at 90 days. We sought to identify important outcome prognosticators. Methods All consecutive patients that presented with an acute anterior circulation ischemic stroke, with adequate CT perfusion imaging, and that underwent emergency endovascular treatment at two centers between […]
